Antisense oligodeoxynucleotides: Internalization, compartmentalization and non-sequence specificity
- 1 December 1996
- journal article
- research article
- Published by Springer Nature in Perspectives in Drug Discovery and Design
- Vol. 4 (1) , 41-50
- https://doi.org/10.1007/bf02172107
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Detection of Ribonuclease H-Generated mRNA Fragments in Human Leukemia Cells Following Reversible Membrane Permeabilization in the Presence of Antisense OligodeoxynucleotidesAntisense Research and Development, 1995
- Nuclear Delivery of Antisense Oligodeoxynucleotides Through Reversible Permeabilization of Human Leukemia Cells with Streptolysin OAntisense Research and Development, 1995
- Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regression.Proceedings of the National Academy of Sciences, 1993
- Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?Science, 1993
- Systemic Administration of a Phosphorothioate Oligonucleotide with a Sequence Complementary to p53 for Acute Myelogenous Leukemia and Myelodysplastic Syndrome: Initial Results of a Phase I TrialAntisense Research and Development, 1993
- Electroporation enhances c-myc antisense oligodeoxynucleotide efficacyNucleic Acids Research, 1993
- Phosphorothioate oligodeoxynucleotides—anti-sense inhibitors of gene expression?Pharmacology & Therapeutics, 1991
- Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?Proceedings of the National Academy of Sciences, 1989
- Physicochemical properties of phospborothioate oligodeoxynucleotidesNucleic Acids Research, 1988
- Automated solid-phase synthesis, separation, and stereochemistry of phosphorothioate analogs of oligodeoxyribonucleotidesJournal of the American Chemical Society, 1984